Live Updates: COVID-19 Cases
  • World 11,869,734
    World
    Confirmed: 11,869,734
    Active: 4,497,887
    Recovered: 6,827,700
    Death: 544,147
  • USA 3,078,722
    USA
    Confirmed: 3,078,722
    Active: 1,598,212
    Recovered: 1,346,755
    Death: 133,755
  • Brazil 1,643,539
    Brazil
    Confirmed: 1,643,539
    Active: 505,217
    Recovered: 1,072,229
    Death: 66,093
  • India 743,481
    India
    Confirmed: 743,481
    Active: 265,783
    Recovered: 457,045
    Death: 20,653
  • Russia 694,230
    Russia
    Confirmed: 694,230
    Active: 219,856
    Recovered: 463,880
    Death: 10,494
  • Peru 309,278
    Peru
    Confirmed: 309,278
    Active: 97,388
    Recovered: 200,938
    Death: 10,952
  • Chile 301,019
    Chile
    Confirmed: 301,019
    Active: 26,340
    Recovered: 268,245
    Death: 6,434
  • Spain 299,210
    Spain
    Confirmed: 299,210
    Active: 270,818
    Recovered: ?
    Death: 28,392
  • UK 286,349
    UK
    Confirmed: 286,349
    Active: 241,958
    Recovered: ?
    Death: 44,391
  • Mexico 261,750
    Mexico
    Confirmed: 261,750
    Active: 70,974
    Recovered: 159,657
    Death: 31,119
  • Iran 245,688
    Iran
    Confirmed: 245,688
    Active: 26,757
    Recovered: 207,000
    Death: 11,931
  • Italy 241,956
    Italy
    Confirmed: 241,956
    Active: 14,242
    Recovered: 192,815
    Death: 34,899
  • Pakistan 234,509
    Pakistan
    Confirmed: 234,509
    Active: 94,713
    Recovered: 134,957
    Death: 4,839
  • Saudi Arabia 217,108
    Saudi Arabia
    Confirmed: 217,108
    Active: 60,252
    Recovered: 154,839
    Death: 2,017
  • Turkey 207,897
    Turkey
    Confirmed: 207,897
    Active: 17,345
    Recovered: 185,292
    Death: 5,260
  • South Africa 205,721
    South Africa
    Confirmed: 205,721
    Active: 104,563
    Recovered: 97,848
    Death: 3,310
  • Germany 198,355
    Germany
    Confirmed: 198,355
    Active: 6,552
    Recovered: 182,700
    Death: 9,103
  • France 168,810
    France
    Confirmed: 168,810
    Active: 61,222
    Recovered: 77,655
    Death: 29,933
  • Bangladesh 168,645
    Bangladesh
    Confirmed: 168,645
    Active: 88,392
    Recovered: 78,102
    Death: 2,151
  • Canada 106,106
    Canada
    Confirmed: 106,106
    Active: 27,571
    Recovered: 69,827
    Death: 8,708
  • China 83,565
    China
    Confirmed: 83,565
    Active: 403
    Recovered: 78,528
    Death: 4,634
  • Netherlands 50,694
    Netherlands
    Confirmed: 50,694
    Active: 44,562
    Recovered: ?
    Death: 6,132
  • S. Korea 13,181
    S. Korea
    Confirmed: 13,181
    Active: 982
    Recovered: 11,914
    Death: 285
  • Australia 8,755
    Australia
    Confirmed: 8,755
    Active: 1,194
    Recovered: 7,455
    Death: 106
  • New Zealand 1,536
    New Zealand
    Confirmed: 1,536
    Active: 22
    Recovered: 1,492
    Death: 22

Hydroxychloroquine-azithromycin combo may be potentially lethal

Author at TechGenyz Health
Hydroxychloroquine
Hydroxychloroquine | Representation image/Freepik

Hydroxychloroquine and azithromycin, which have been proposed for treatment of COVID-19 patients, are a potentially lethal combination and may have a serious impact on the cardiovascular system, according to a study.

The researchers, including those from Vanderbilt University and Stanford University in the US, carried out an observational, retrospective meta-analysis of a WHO database encompassing over 21 million adverse event case reports.

The reports span across all medication classes from over 130 countries between November 14, 1967, and March 1, 2020 -- mainly before the COVID-19 pandemic.

The study, published in the journal Circulation, compared cardiovascular adverse-drug-reactions (CV-ADRs) in patients who received hydroxychloroquine, azithromycin, or the combination of both medications with all other cardiovascular medications in the database.

Hydroxychloroquine and azithromycin, alone or in combination, have been proposed for treatment of COVID-19 patients, the researchers said.

They explained that reports of potentially lethal acute cardiac proarrhythmogenic effects -- promoting irregular heart rhythms -- have been described mainly with azithromycin but also with hydroxychloroquine.

Their combination yielded an even stronger signal, the scientists said.

Hydroxychloroquine was also associated with potentially lethal heart failure when exposure was prolonged over several months, according to the researchers.

From the more than 21 million case reports of adverse drug reactions, the researchers extracted case reports for hydroxychloroquine and azithromycin, alone or in combination.

They found that 76,822 adverse event reports were associated with hydroxychloroquine alone, and in 28.4 percent of those cases (21,808), the drug was suspected to be associated with the adverse event.

The study found that 89,692 adverse event reports were associated with azithromycin alone, and in 60.8 per cent of those cases (54,533), the medication was suspected to be associated with the adverse events.

The researchers said 607 adverse event reports were associated with the combination of both medications.

Hydroxychloroquine was significantly associated with the development of conduction disorders, and heart failure, they said.

On Monday, the World Health Organization also suspended testing hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus said.

We Are Hiring

Subscribe